Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

THERAPY AND CLINICAL TRIALS: Edited by Anton F. Stalenhoef and John J.P. Kastelein

Inhibition of ApoCIII: the next PCSK9?

Bernelot Moens, Sophie J.; van Capelleveen, Julian C.; Stroes, Erik S.G.

Author Information
doi: 10.1097/MOL.0000000000000130
  • Buy


© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins